PMID- 37767795 OWN - NLM STAT- MEDLINE DCOM- 20240418 LR - 20240418 IS - 1875-6360 (Electronic) IS - 1573-3971 (Linking) VI - 20 IP - 2 DP - 2024 TI - Extracorporeal Shock Wave Therapy as Regenerative Medicine in Knee Osteoarthritis: Pre-Experiment for Matrix Metalloproteinase-3 Evaluation. PG - 176-181 LID - 10.2174/0115733971230928230919053949 [doi] AB - BACKGROUND: Knee osteoarthritis (KOA) is currently treated by regenerative therapies that aim to inhibit arthritic degeneration. Extracorporeal shock wave therapy (ESWT) is one of the physical regenerative approaches used for KOA management. However, little is known regarding the impact of shock wave treatment on matrix metalloproteinase-3 (MMP-3), which is one of the enzymes mediating cartilage degradation. OBJECTIVES: To evaluate the effect of ESWT on MMP-3 levels and pain intensity in patients with KOA. METHODS: Fourteen patients diagnosed with Kellgren Lawrence, grades 2 and 3 KOA were recruited for the study. ESWT piezo shockwave was applied once a week for six weeks. MMP-3 levels in the blood were measured pre-test, mid-test (three weeks after therapy) and post-test (one week after the last session) by enzyme-linked immunosorbent assay (ELISA). The perceived pain was recorded at each session by the Wong Becker Face Scale. RESULTS: The median pre-test, mid-test and post-test MMP-3 levels were 19.92 ng/mL, 15.89 ng/mL and 18.82 ng/mL, respectively, and there were significant differences between the pre-test and mid-test, and the pre-test and post-test values (p < 0.05). The pain scores also decreased significantly over the period of intervention. CONCLUSION: MMP-3 levels decreased significantly in KOA patients after ESWT, and the decline was most obvious after 3 weeks of therapy. Therefore, EWST should be considered as a suitable treatment option for KOA. CI - Copyright(c) Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. FAU - Randita, Amandha Boy Timor AU - Randita ABT AUID- ORCID: 0000-0001-9739-2968 AD - Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Universitas Airlangga - Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. FAU - Wardhani, Indrayuni Lukitra AU - Wardhani IL AUID- ORCID: 0000-0002-9889-9039 AD - Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Universitas Airlangga - Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. FAU - Andriati, Andriati AU - Andriati A AD - Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Universitas Airlangga - Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. FAU - Wardani, Nurul Kusuma AU - Wardani NK AD - Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Universitas Airlangga - Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. FAU - Philothra, Petrina Theda AU - Philothra PT AD - Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Universitas Airlangga - Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. FAU - Subadi, Imam AU - Subadi I AUID- ORCID: 0000-0002-8575-2740 AD - Department of Physical Medicine and Rehabilitation, Airlangga Teaching Hospital, Surabaya, Indonesia. FAU - Melaniani, Soenarnatalina AU - Melaniani S AD - Department of Epidemiology, Biostatistics, Population Studies, and Health Promotion, Faculty of Public Health, Universitas Airlangga, Surabaya, Indonesia. LA - eng GR - 1306/UN3.1.1/PT/2022/Universitas Airlangga/ PT - Journal Article PL - United Arab Emirates TA - Curr Rheumatol Rev JT - Current rheumatology reviews JID - 101261938 RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) SB - IM MH - Humans MH - *Osteoarthritis, Knee/therapy MH - *Extracorporeal Shockwave Therapy MH - Matrix Metalloproteinase 3 MH - Regenerative Medicine MH - Pain Measurement OTO - NOTNLM OT - Knee osteoarthritis OT - degenerative diseases OT - extracorporeal shock wave therapy OT - kellergren lawrence. OT - matrix metalloproteinase-3 OT - regenerative medicine EDAT- 2023/09/28 12:42 MHDA- 2024/04/18 06:44 CRDT- 2023/09/28 06:34 PHST- 2022/12/01 00:00 [received] PHST- 2023/08/01 00:00 [revised] PHST- 2023/08/16 00:00 [accepted] PHST- 2024/04/18 06:44 [medline] PHST- 2023/09/28 12:42 [pubmed] PHST- 2023/09/28 06:34 [entrez] AID - CRR-EPUB-134658 [pii] AID - 10.2174/0115733971230928230919053949 [doi] PST - ppublish SO - Curr Rheumatol Rev. 2024;20(2):176-181. doi: 10.2174/0115733971230928230919053949.